This year’s Breakthrough Prizes honor advances in CAR T cancer therapies, cystic fibrosis, and Parkinson’s disease.

Bioengineered bacteria sneak past solid tumor defenses to guide CAR T cells’ attacks.

Animals with human cells could provide donor organs or help us understand neuropsychiatric disorders.

New single cell technologies make previously unattainable discoveries a reality.

A reference sequence for this emerging model organism will facilitate research on type 2 diabetes and the health effects of circadian rhythm disruption.

A snapshot of the most highly ranked articles in microbiology and related areas, from Faculty of 1000

Gaining a better understanding of the dynamic and reciprocal interactions between cancer cells and the tumor microenvironment is essential for improving patient diagnosis and treatment.

Metagenomic sequencing can help detect unknown pathogens, but its widespread use faces challenges.

At The Scientist, we are strengthening our roots while reaching for the sky.

The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.